Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
As of close of business last night, Cassava Sciences Inc’s stock clocked out at $19.64, down -7.31% from its previous closing price of $21.19. In other words, the price has decreased by -$7.31 from its previous closing price. On the day, 1.32 million shares were traded. SAVA stock price reached its highest trading level at $21.195 during the session, while it also had its lowest trading level at $19.47.
Ratios:
To gain a deeper understanding of SAVA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.13 and its Current Ratio is at 9.13. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On July 15, 2021, Cantor Fitzgerald Downgraded its rating to Neutral which previously was Overweight but kept the price unchanged to $100.
Maxim Group reiterated its Buy rating for the stock on July 07, 2021, while the target price for the stock was revised from $80 to $190.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 23 ’23 when ROBERTSON SANFORD bought 30,000 shares for $17.45 per share. The transaction valued at 523,500 led to the insider holds 886,851 shares of the business.
Barry Richard bought 16,571 shares of SAVA for $275,907 on Aug 22 ’23. The Director now owns 293,477 shares after completing the transaction at $16.65 per share. On Aug 21 ’23, another insider, Barry Richard, who serves as the Director of the company, bought 1,906 shares for $16.80 each. As a result, the insider paid 32,021 and bolstered with 276,906 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SAVA now has a Market Capitalization of 849347456 and an Enterprise Value of 727807168.
Stock Price History:
The Beta on a monthly basis for SAVA is -0.32, which has changed by -0.13972843 over the last 52 weeks, in comparison to a change of 0.2006725 over the same period for the S&P500. Over the past 52 weeks, SAVA has reached a high of $32.10, while it has fallen to a 52-week low of $12.32. The 50-Day Moving Average of the stock is -10.56%, while the 200-Day Moving Average is calculated to be -7.96%.
Shares Statistics:
It appears that SAVA traded 731.79K shares on average per day over the past three months and 1413480 shares per day over the past ten days. A total of 42.24M shares are outstanding, with a floating share count of 40.13M. Insiders hold about 7.17% of the company’s shares, while institutions hold 32.66% stake in the company. Shares short for SAVA as of 1711584000 were 11788533 with a Short Ratio of 16.11, compared to 1709164800 on 11317701. Therefore, it implies a Short% of Shares Outstanding of 11788533 and a Short% of Float of 29.310000000000002.
Earnings Estimates
Investors are keenly observing as 2 analysts analyze and rate the current performance of Cassava Sciences Inc (SAVA) in the stock market.On average, analysts expect EPS of -$0.46 for the current quarter, with a high estimate of -$0.41 and a low estimate of -$0.51, while EPS last year was -$0.58. The consensus estimate for the next quarter is -$0.45, with high estimates of -$0.42 and low estimates of -$0.48.
Analysts are recommending an EPS of between -$2.01 and -$2.28 for the fiscal current year, implying an average EPS of -$2.14. EPS for the following year is -$0.47, with 2 analysts recommending between $1.67 and -$2.62.
